Training Drug Treatment Providers to Adopt Evidence-Based Practices
Principal Investigator
|
Assistant Professor (Research) |
Funding Source
NIDA
Description
This two-year R21 grant was awarded by NIDA in May, 2007. Project Co-Investigators are Nancy Barnett, PhD and Peter Monti, PhD. The purpose of the project is to evaluate a dissemination model developed by the Addiction Technology Transfer Center of New England (ATTC-NE) to promote the adoption and utilization of evidence-based treatments for substance abuse. The ATTC-NE model is one of only a few national training models to address both individual and organizational factors known to significantly influence the adoption and utilization of evidence-based practices. The principal aim of this project is to test the hypothesis that the ATTC-NE model promotes increased adoption and utilization of Contingency Management (CM) as a treatment for opiate addiction among treatment providers across 12 integrated satellite methadone treatment clinics. Contingency Management is particularly compatible with existing treatment methods for opiate addiction, and provides an ideal test case to model and evaluate different dissemination strategies. Forty-eight treatment providers nested within and across the 12 clinics will receive standard (didactic) training in CM. Using an additive design, half of the sites will receive additional training and support in accordance with the ATTC-NE model. Adoption of CM will be measured in two ways. First, treatment providers will be classified as adopters or non-adopters based on any clinical use of CM incentives (e.g. prize drawings, tokens, vouchers, etc.). Second, utilization of CM by adopters will be quantified based on the number of clients with whom they include the clinical use of CM incentives. We will further examine the impact of the ATTC-NE model on: 1) readiness to adopt CM among treatment providers across personal and organizational factors, 2) treatment provider attitudes toward CM, and 3) treatment provider attitudes toward the training methods employed. Participating treatment providers in both groups will be assessed at baseline (initial CM training), 3, and 12 months to evaluate the impact of the ATTC-NE model on outcomes of interest. Likely effect sizes specific to all aims will be established to prepare for a larger follow-up study.